𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The use of low-dose protracted oral clofarabine in a patient with myelodysplastic syndrome after failing 5-azacitidine

✍ Scribed by Al Ustwani, Omar; Greene, Jessica D.; Wetzler, Meir

Book ID
122289254
Publisher
Elsevier
Year
2013
Tongue
English
Weight
168 KB
Volume
2
Category
Article
ISSN
2213-0489

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized study of 2 dose levels of i
A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome
✍ Stefan Faderl; Guillermo Garcia-Manero; Elias Jabbour; Farhad Ravandi; Gautam Bo πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 181 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: Clofarabine is a nucleoside analog with activity in myeloid malignancies. Experience in myelodysplastic syndrome (MDS) is limited. ## METHODS: The goal of this study was to evaluate the activity and safety of 2 different doses (15 mg/m^2^ vs 30 mg/m^2^ daily Γ— 5 days)